ABX Datasheet Product Number 9830

ABX advanced biochemical compounds


Catalogue Number	Product	Order number / Unit

9830	DOTA-Lanreotide trifluoroacetate	9830.0001: 1 mg per vial 9830.0010: 10 mg per vial Please inquire for customized filling and bulk quantities.
	Precursor for radiolabelled DOTA-Lanreotide Ligand for somatostatin receptors


	Molar Mass: 1482.73
	C₇₀H₉₅N₁₅O₁₇S₂
	[213187-44-1] (net peptide)

	Colourless to off-white freeze-dried solid packaged in dark glass screw cap vials.


	Purity: ≥ 95 %
	Certificates: CoA; MS (identity) and HPLC (purity)
	Chemical Name: CA index name: L-Threoninamide, 3-(2-naphthalenyl)-N-[[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-alanyl-L-cysteinyl-L-Tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2→7) disulfide
	Synonymes: DOTA-BIM-23014
	Literature: 1. Smith-Jones P.M. et al. DOTA-Lanreotide: a novel somatostatin analog for tumor diagnosis and therapy. Endocrinology 1999, 140, 5136 - 5148.
	2. Banerjee S. et al. ¹⁷⁷Lu-DOTA-lanreotide: a novel tracer as a targeted agent for tumor therapy. Nucl. Med. Biol. 2004, 31, 753-759.



	date of product catalogue issue: 05 April 2012